2026-08-25 · glp-1, injection technique, ozempic, wegovy, zepbound, mounjaro, saxenda, self-injection, patient guide
Written by Nora Kim
Nora Kim is a WeightFAQ staff writer who translates clinical, surgical, and pharmacological weight-loss research into plain-English guidance. She covers the GLP-1 landscape — semaglutide, tirzepatide, and next-generation drugs — alongside bariatric surgery types, post-op nutrition protocols, and revision options. Her articles also address type 2 diabetes remission, cardiovascular risk, PCOS, fatty liver, night eating syndrome, sarcopenic obesity, and how common medications like antipsychotics, statins, and antidepressants affect weight. Nora writes for readers weighing serious clinical decisions and wanting a clear read on evidence, safety, cost, and realistic outcomes.
10 min read
Medically reviewed on Aug 25, 2026
GLP-1 Injection Technique: How to Give Yourself the Shot (2026)
1. The 60-second overview
The eight-step version for readers who want the answer first:
- Wash your hands with soap and water.
- Let the pen sit out for about 15 minutes to reach room temperature — cold medication stings more going in.
- Check the pen. Confirm drug name, dose in the window, expiry, and that the solution is clear and colorless.
- Alcohol-swab the site and let it air-dry.
- Pinch a small amount of skin between thumb and index finger.
- Insert at 90 degrees (straight in). Use 45 degrees only if you are very lean and using a longer 6 or 8 mm needle from a compounded-vial syringe.
- Press the button (or press an auto-injector firmly against the skin) and count to 6. On Wegovy, Zepbound, and Mounjaro auto-injectors, listen for two clicks — start and end — keep pressed until the second click, then hold another 6 seconds.
- Withdraw straight out without recapping and drop the used pen or needle into a sharps container. Log the date and site.
The sections below cover each step in the detail a first-time patient needs.
2. The 3 approved subcutaneous injection sites
The FDA-approved subcutaneous sites for every weekly GLP-1 are the same:
- Abdomen. Easiest to see, pinch, and reach. Stay at least 2 inches away from the belly button in every direction — that region has different underlying tissue and is not appropriate for injection. The rest of the abdomen, from below the ribs to the top of the pelvis, is fair game.
- Front of the thigh. Comfortable and easy to self-inject. Use the middle third of the thigh, roughly a handspan below the hip crease and a handspan above the knee.
- Upper outer arm. Fine for a partner or caregiver injection but hard to self-inject because you cannot reliably see the site or pinch the skin. Use a mirror or switch to the abdomen or thigh that week.
Per the Ozempic, Wegovy, Zepbound, Mounjaro, and Saxenda US prescribing information, absorption is broadly similar across all three sites for these weekly agonists. Site choice is about comfort, rotation, and pinch-ability — not pharmacokinetics.
For rotation, think of a “6-pack”: upper-left and upper-right abdomen, lower-left and lower-right abdomen, left thigh, right thigh. That gives six rotation zones, plus two arm zones if you have a partner to help.
3. How to prime and dispense — by pen
The specific mechanics differ across the pens on the US market. Use the row below for the drug you were actually shipped, not the one you saw in a video.
| Drug (pen type) | Prime step | Dose-selection step | Dispense step | Needle used |
|---|---|---|---|---|
| Ozempic (multi-dose pen, dial) | Attach new pen needle each dose; prime with pen up until a drop appears | Turn dose selector to prescribed dose (0.25, 0.5, 1, 2 mg) | 90°, press and hold button until counter returns to 0, hold 6 s | 4 mm 32G pen needle, attached each dose |
| Wegovy (single-dose pen, no dial) | No priming — dose pre-set | One pen = one dose (0.25, 0.5, 1.0, 1.7, 2.4 mg) | Press firmly against skin, first click starts dose, hold 6–10 s until second click | 5 mm 32G needle, internal |
| Zepbound / Mounjaro (single-dose auto-injector) | No priming | One pen = one dose (2.5–15 mg per pen) | Uncap, press against skin, hold until first click, keep pressed 6–10 s until second click | 5 mm 29G needle, internal |
| Saxenda (multi-dose pen, dial) | Attach new pen needle each dose; prime with pen up until drop appears | Dial to prescribed dose (0.6, 1.2, 1.8, 2.4, 3.0 mg) | 90°, press and hold until counter returns to 0, hold 6 s | 4 mm 32G pen needle, attached each dose |
| Compounded semaglutide / tirzepatide (vial) | Wipe vial top with alcohol, draw prescribed volume into U-100 insulin syringe, tap out air bubbles | Volume in units = prescribed | 90° with pinched skinfold, depress plunger fully, hold 5 s | 6 mm 31G insulin syringe (or as compounder specifies) |
Two notes on the compounded row. First, always confirm the concentration (mg per mL) and the resulting units-to-mg conversion with your pharmacist before the first dose — a math error is the most common source of over- or under-dosing. Second, if the compounded solution is not clear and colorless, do not use it; call the pharmacy.
4. Needle length and 45° vs 90° angle
Modern pen needles are short. The 4 mm needle used on Ozempic and Saxenda and the 5 mm needle used on Wegovy, Zepbound, and Mounjaro follow the Forum for Injection Technique (FIT) consensus (Frid 2016, Mayo Clin Proc), which established that a 4 mm needle reliably reaches subcutaneous fat in essentially all adults at a 90-degree angle without a pinch. Most people find a light pinch more comfortable, and the pinch does not change delivery depth with a 4 or 5 mm needle.
The 45-degree angle is a holdover from older, longer insulin syringes (12.7 mm and 8 mm) that risked intramuscular delivery in lean people at 90 degrees. It still applies if you are drawing a compounded dose with a 6 mm or 8 mm insulin syringe and you have a low BMI (under about 22).
Practical rule: match the technique to the needle you were actually shipped, not to the video you watched. Pen needle (4 or 5 mm) → 90 degrees, light pinch optional. Insulin syringe (6 mm or longer) → 90 degrees with a pinch for most adults, 45 degrees only if you are very lean.
5. Site rotation schedule
Repeated injection at the same spot can, over months, cause a subcutaneous fat nodule called lipohypertrophy — well documented in insulin users (Blanco 2013, Diabetes Metab) and a reasonable long-term concern with weekly GLP-1 injections. The nodule can change absorption unpredictably, so rotation is a durable-health practice — not something you feel a difference from in one week.
A simple 4-week rotation:
| Week | Injection site | Notes |
|---|---|---|
| Week 1 | Left abdomen, upper | 2+ inches lateral of belly button |
| Week 2 | Right thigh, mid-front | Sitting or leg extended |
| Week 3 | Right abdomen, upper | Mirror image of week 1 |
| Week 4 | Left thigh, mid-front | Mirror image of week 2 |
Repeat the cycle. If someone can help with an upper-arm injection, add weeks 5 and 6 for the arms. Write the site down each week — a phone note or a paper log is the simplest way to avoid reusing the same square inch.
6. Cold storage, warming to room temp, and travel
The refrigerator (2 to 8 degrees Celsius, or 36 to 46 degrees Fahrenheit) is the default for every GLP-1 pen — that is how it ships and where it lives until you use it.
Room temperature “in use” allowances per each product’s US label:
- Ozempic — up to 56 days at room temperature once the pen is in use
- Wegovy — up to 28 days at room temperature per single-use pen
- Saxenda — up to 30 days at room temperature once in use
- Zepbound and Mounjaro — up to 21 days at room temperature per single-use pen
Room temperature is defined as up to about 30 degrees Celsius (86 degrees Fahrenheit). Do not freeze — a pen that has frozen must be discarded, even if it looks fine after thawing.
Warming to room temp before an injection is a comfort step, not a storage step. Cold medication stings more going in. Take the pen out of the fridge about 15 minutes before you plan to inject. Never microwave, never place it in hot water, and never leave it in a hot car.
Travel. Use an insulated pouch with a gel ice pack; keep the pen off direct contact with ice so it does not freeze. The TSA disability-and-medical-conditions page allows medically necessary medications, needles, and syringes in carry-on baggage — declare them at security if asked, and keep the pen in its labeled carton with a prescription printout. Do not check a GLP-1 pen in the cargo hold. For the paperwork side of a prescription, see GLP-1 cost and insurance coverage.
7. Sharps disposal
Used pen needles and single-use auto-injector pens are medical sharps. Do not put uncapped needles in household trash. The four accepted disposal channels:
- FDA-cleared sharps container. Any pharmacy sells one for a few dollars, and you can order online. When about three-quarters full, seal it and take it to a pharmacy, doctor’s office, or municipal drop-off.
- Manufacturer mail-back programs. Novo Care (Ozempic, Wegovy, Saxenda) and Lilly (Mounjaro, Zepbound via LillyDirect) ship a pre-paid, pre-labeled sharps container and cover return postage.
- Household hazardous waste drop-off. Most municipalities run a household-hazardous-waste day or permanent drop-off center that accepts sharps in an FDA-cleared container. Check your local waste-management website.
- Empty rigid-plastic bottle with a screw-on cap (a laundry-detergent bottle is the traditional example), cap taped shut and labeled “DO NOT RECYCLE — SHARPS.” This option is only legal in some jurisdictions; laws vary. When unsure, use one of the first three channels.
Never fill above the manufacturer’s fill line, never reach in to press needles down, and never dump the container into a recycling bin.
8. Site reactions and what to expect
Most injection-site reactions are minor and resolve without intervention:
- Small red spot or bruise at the site — normal, resolves in 3 to 5 days. Ice for 10 minutes if tender.
- Mild sting during the injection — reduced by letting the pen reach room temp first, and by pressing the button slowly on dial pens.
- A small bubble of clear medication on the skin at withdrawal (a “leak”). Partial dose loss. You cannot measure exactly how much was lost. Take the next dose on schedule and do not double up. Improve the hold time on the next injection.
- Missed dose. Ozempic: within 5 days of the scheduled day → take it; longer → skip. Wegovy: within 2 days → take it; longer → skip. Zepbound and Mounjaro: within 4 days → take it; longer → skip. Saxenda is daily — if you miss a day, just resume with the next scheduled dose and do not double up. Never inject two doses fewer than 72 hours apart.
- A persistent lump or nodule at a repeatedly used site — possible early lipohypertrophy. Rotate to a different site, avoid the lump for 3 to 6 months, and mention it to your prescriber.
For the nausea, constipation, reflux, and dose-hold logic outside injection technique, see managing GLP-1 side effects.
9. What NOT to do
Five concrete anti-actions:
- Do not re-use a needle. Pen needles are single-use. A reused needle is duller, hurts more, and increases infection risk.
- Do not inject into a bruise, scar, tattoo, stretch mark, or the skin over a hernia. Absorption is unpredictable through altered tissue.
- Do not warm a pen in a microwave, on a heater, or in hot water. Room-temperature ambient is the correct warming method.
- Do not shake the pen. GLP-1 solutions do not need shaking. If the label allows gentle inversion, invert 2 or 3 times — do not shake.
- Do not switch injection style mid-dose. If you pull an auto-injector off the skin before the second click, the dose is interrupted. Take the next dose on your scheduled day and improve the hold on the next one, unless a catch-up window listed above applies.
10. First-injection specific guidance
Four practical rules for the first shot:
- Watch the manufacturer’s Instructions For Use video for your specific device. Search the drug name plus “instructions for use.” Novo Nordisk (Ozempic, Wegovy, Saxenda) and Eli Lilly (Zepbound, Mounjaro) both publish 2- to 3-minute official videos.
- Do the first injection at home — not in a car, hotel, or public restroom. You want a stable surface, good light, and time to sit down afterward.
- Do it in the morning rather than at night, so you have all day to notice any reaction.
- Keep the carton and pen label. In the rare case of an adverse-event report, you or your prescriber will need the lot number.
11. When to escalate to the prescriber or ER
Red-flag symptoms that should override the calendar and prompt a same-day call to your prescriber or a trip to the emergency department:
- Severe abdominal pain radiating to the back, especially with nausea and vomiting — rule out pancreatitis. ER-level on any GLP-1.
- Persistent vomiting for more than 24 hours, or an inability to keep any fluids down.
- Signs of acute kidney injury — dark or amber urine, minimal urine output, dizziness on standing, marked fatigue after a vomiting or diarrhea episode.
- Anaphylaxis — throat tightness, tongue or facial swelling, difficulty breathing, hives spreading beyond the injection site. 911 event; use an EpiPen if you have one.
- Severe injection-site infection — spreading redness, warmth, fever, or a discharging wound at a site. Same-day-clinic or ER-level.
For the class safety profile, boxed warnings, and contraindications, see weight loss drug safety; for symptom-by-symptom management beyond injection technique, see managing GLP-1 side effects.
Sources
- Ozempic, Wegovy, and Saxenda US Prescribing Information (Novo Nordisk)
- Zepbound and Mounjaro US Prescribing Information (Eli Lilly)
- Frid AH et al. 2016, Mayo Clinic Proceedings — FIT consensus on needle length and technique
- Blanco M et al. 2013, Diabetes & Metabolism — lipohypertrophy in insulin (cited as analog)
- FDA safe sharps disposal guidance (fda.gov/safe-sharps)
- TSA disability-and-medical-conditions page — medications and needles in carry-on